Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4866014 | 1.00 | CYP19A1 (0.37) | CYP19A1 | |
| SCHEMBL28975120 | 0.77 | — | — | |
| SCHEMBL11583404 | 0.77 | CYP19A1 (0.39) | CYP19A1 | |
| SCHEMBL18461260 | 0.75 | — | — | |
| SCHEMBL31564941 | 0.74 | EDNRA (0.32) | — | |
| SCHEMBL18461259 | 0.74 | — | — | |
| SCHEMBL14440888 | 0.72 | — | — | |
| SCHEMBL29322980 | 0.71 | AKR1C3 (0.34) | — | |
| SCHEMBL18458916 | 0.71 | — | — | |
| SCHEMBL31564933 | 0.70 | TRPA1 (0.33) | CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080312465-A1 | INTERMEDIATE COMPOUNDS IN THE SYNTHESIS OF DRONABINOL | ALPHORA RESEARCH INC. (CA) | 2008-12-18 | — | — | US | claimed |
| US-7323576-B2 | Synthetic route to dronabinol | ALPHORA RESEARCH INC. (CA) | 2008-01-29 | — | — | US | claimed |
| US-20060074252-A1 | Synthetic route to dronabinol | SANDOZ INC. | 2006-04-06 | — | — | US | claimed |
| US-20220413385-A1 | RADIATION-SENSITIVE RESIN COMPOSITION AND METHOD OF FORMING RESIST PATTERN | JSR CORPORATION (JP) | 2022-12-29 | — | — | US | disclosed |
| US-20080312465-A1 | INTERMEDIATE COMPOUNDS IN THE SYNTHESIS OF DRONABINOL | ALPHORA RESEARCH INC. (CA) | 2008-12-18 | — | — | US | disclosed |
| US-7323576-B2 | Synthetic route to dronabinol | ALPHORA RESEARCH INC. (CA) | 2008-01-29 | — | — | US | disclosed |
| US-20060074252-A1 | Synthetic route to dronabinol | SANDOZ INC. | 2006-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080312465-A1 | INTERMEDIATE COMPOUNDS IN THE SYNTHESIS OF DRONABINOL | CNR1, CNR2, CYP8B1 | CYP19A1 1160/4885 |
| US-20060074252-A1 | Synthetic route to dronabinol | CNR1, CNR2, CYP8B1 | CYP19A1 1011/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.